Evidence map›Paper›PMID 30705270›Full record

ArticleNature communications2019

Microglia are an essential component of the neuroprotective scar that forms after spinal cord injury.

Victor Bellver-Landete, Floriane Bretheau, Benoit Mailhot, Nicolas Vallières, Martine Lessard, Marie-Eve Janelle, Nathalie Vernoux, Marie-Ève Tremblay, Tobias Fuehrmann, Molly S Shoichet and 1 more

Abstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 371 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
371citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

371 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Injury and therapy in a human spinal cord organoid.Nature biomedical engineering · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

311 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Victor Bellver-LandeteAxe neurosciences du Centre de recherche du Centre hospitalier universitaire (CHU) de Québec-Université Laval et Département de médecine moléculaire de l'Université Laval, Québec, QC, G1V 4G2, Canada.
Floriane BretheauAxe neurosciences du Centre de recherche du Centre hospitalier universitaire (CHU) de Québec-Université Laval et Département de médecine moléculaire de l'Université Laval, Québec, QC, G1V 4G2, Canada.
Benoit MailhotAxe neurosciences du Centre de recherche du Centre hospitalier universitaire (CHU) de Québec-Université Laval et Département de médecine moléculaire de l'Université Laval, Québec, QC, G1V 4G2, Canada.
Nicolas VallièresAxe neurosciences du Centre de recherche du Centre hospitalier universitaire (CHU) de Québec-Université Laval et Département de médecine moléculaire de l'Université Laval, Québec, QC, G1V 4G2, Canada.
Martine LessardAxe neurosciences du Centre de recherche du Centre hospitalier universitaire (CHU) de Québec-Université Laval et Département de médecine moléculaire de l'Université Laval, Québec, QC, G1V 4G2, Canada.
Marie-Eve JanelleDépartement de biologie-biotechnologie du Cégep de Lévis-Lauzon, Lévis, QC, Canada, G6V 6Z9.
Nathalie VernouxAxe neurosciences du Centre de recherche du Centre hospitalier universitaire (CHU) de Québec-Université Laval et Département de médecine moléculaire de l'Université Laval, Québec, QC, G1V 4G2, Canada.
Marie-Ève TremblayAxe neurosciences du Centre de recherche du Centre hospitalier universitaire (CHU) de Québec-Université Laval et Département de médecine moléculaire de l'Université Laval, Québec, QC, G1V 4G2, Canada.ORCID http://orcid.org/0000-0003-2863-9626
Tobias FuehrmannDepartment of Chemical Engineering & Applied Chemistry, University of Toronto, Toronto, ON, M5S 3E1, Canada.ORCID http://orcid.org/0000-0003-1857-4806
Molly S ShoichetDepartment of Chemical Engineering & Applied Chemistry, University of Toronto, Toronto, ON, M5S 3E1, Canada.
Steve LacroixAxe neurosciences du Centre de recherche du Centre hospitalier universitaire (CHU) de Québec-Université Laval et Département de médecine moléculaire de l'Université Laval, Québec, QC, G1V 4G2, Canada. Steve.Lacroix@crchul.ulaval.ca.ORCID http://orcid.org/0000-0003-0781-6371

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The role of microglia in spinal cord injury (SCI) remains poorly understood and is often confused with the response of macrophages. Here, we use specific transgenic mouse lines and depleting agents to understand the response of microglia after SCI. We find that microglia are highly dynamic and proliferate extensively during the first two weeks, accumulating around the lesion. There, activated microglia position themselves at the interface between infiltrating leukocytes and astrocytes, which proliferate and form a scar in response to microglia-derived factors, such as IGF-1. Depletion of microglia after SCI causes disruption of glial scar formation, enhances parenchymal immune infiltrates, reduces neuronal and oligodendrocyte survival, and impairs locomotor recovery. Conversely, increased microglial proliferation, induced by local M-CSF delivery, reduces lesion size and enhances functional recovery. Altogether, our results identify microglia as a key cellular component of the scar that develops after SCI to protect neural tissue.

Indexed as

AnimalsCell MovementFlow CytometryFluorescent Antibody TechniqueIn Situ HybridizationInsulin-Like Growth Factor IMiceMicrogliaMicroscopy, ConfocalMicroscopy, ImmunoelectronNeuronsOligodendrogliaSpinal Cord InjuriesInsulin-Like Growth Factor I

Identifiers

PMID30705270
PMCPMC6355913

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.